Abstract
Despite the constant exposure to genomic insults that may lead to malignancy, cancer is surprisingly a relatively rare occurrence, and this is largely credited to an elaborate network of endogenous tumor suppression. Many effectors of tumor suppression have been identified, and their functions when activated in damaged cells have in large part been elucidated. What is less clear is whether there are common target gene(s) of tumor suppression, whose expression must be ablated in order to block transformation and preserve cellular homeostasis. Fresh experimental evidence suggests that silencing of the mitotic regulator and cell death inhibitor, survivin, is a universal requirement for successful tumor suppression in humans.
MeSH Terms
Apoptosis
Gene Expression Regulation, Neoplastic
Gene Silencing
Humans
Inhibitor of Apoptosis Proteins
Microtubule-Associated Proteins/metabolism
PTEN Phosphohydrolase/metabolism
Survivin
Tumor Suppressor Proteins/metabolism
Chemicals
BIRC5 protein, human
Inhibitor of Apoptosis Proteins
Microtubule-Associated Proteins
Survivin
Tumor Suppressor Proteins
PTEN Phosphohydrolase
PTEN protein, human
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Guha Minakshi
Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Altieri Dario C
References (27)
27 references, click to expand
-
Mitosis-independent survivin gene expression in vivo and regulation by p53.
Cancer Res. 2006 Apr 1;66(7):3392-5
PMID: 16585159
-
Aberrant regulation of survivin by the RB/E2F family of proteins.
J Biol Chem. 2004 Sep 24;279(39):40511-20
PMID: 15271987
-
Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
Hum Gene Ther. 2007 Jul;18(7):589-602
PMID: 17630837
-
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.
Clin Cancer Res. 2008 Aug 15;14(16):5000-5
PMID: 18698017
-
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation.
Cell. 2004 May 14;117(4):421-6
PMID: 15137936
-
Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
J Invest Dermatol. 1999 Dec;113(6):1076-81
PMID: 10594755
-
Survivin and molecular pathogenesis of colorectal cancer.
Lancet. 2003 Jul 19;362(9379):205-9
PMID: 12885482
-
Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax.
Int J Cancer. 2005 Jul 20;115(6):967-74
PMID: 15729715
-
Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis.
Mol Biol Cell. 2009 Apr;20(7):2041-8
PMID: 19211844
-
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.
Mol Cell. 2008 Oct 10;32(1):11-20
PMID: 18851829
-
The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression.
Cancer Res. 1999 Jul 1;59(13):3143-51
PMID: 10397257
-
AKT/PKB signaling: navigating downstream.
Cell. 2007 Jun 29;129(7):1261-74
PMID: 17604717
-
Colonic crypt changes during adenoma development in familial adenomatous polyposis: immunohistochemical evidence for expansion of the crypt base cell population.
Am J Pathol. 2004 Nov;165(5):1489-98
PMID: 15509520
-
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Oncogene. 2002 Apr 18;21(17):2613-22
PMID: 11965534
-
Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.
J Biol Chem. 2002 Feb 1;277(5):3247-57
PMID: 11714700
-
The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity.
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20344-9
PMID: 18077326
-
Endogenous tumor suppression mediated by PTEN involves survivin gene silencing.
Cancer Res. 2009 Jun 15;69(12):4954-8
PMID: 19470765
-
IAPs: what's in a name?
Mol Cell. 2008 Apr 25;30(2):123-35
PMID: 18439892
-
Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis.
Cancer Res. 2008 Jul 1;68(13):5273-81
PMID: 18593928
-
Cancer-specific activation of the survivin promoter and its potential use in gene therapy.
Cancer Gene Ther. 2004 Nov;11(11):740-7
PMID: 15359286
-
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity.
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7391-6
PMID: 17463090
-
The role of PTEN signaling perturbations in cancer and in targeted therapy.
Oncogene. 2008 Sep 18;27(41):5477-85
PMID: 18794882
-
Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
J Mol Endocrinol. 2006 Dec;37(3):377-90
PMID: 17170079
-
Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1).
Genes Dev. 2004 May 1;18(9):1060-71
PMID: 15132996
-
Survivin, cancer networks and pathway-directed drug discovery.
Nat Rev Cancer. 2008 Jan;8(1):61-70
PMID: 18075512
-
Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.
Oncogene. 2006 May 11;25(20):2860-72
PMID: 16407838
-
Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer.
Cancer Res. 2001 Dec 15;61(24):8664-7
PMID: 11751382